CHAT Gene

📖 Wiki Page

gene1171 wordssynced 2026-04-02

CHAT Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CHAT Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CHAT</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>10q11.23</td>
</tr>
<tr>
<td class="label">Gene Length</td>
<td>~46 kb</td>
</tr>
<tr>
<td class="label">Exons</td>
<td>14</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Acetyltransferase (choline O-acetyltransferase)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>68-82 kDa</td>
</tr>
<tr>
<td class="label">Primary Localization</td>
<td>Cytoplasm of cholinergic neurons</td>
</tr>
<tr>
<td class="label">Disease Associations</td>
<td>Alzheimer's disease, congenital myasthenic syndrome, PD</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Basal Forebrain (NBM, HDB)</td>
<td>Cortical/hippocampal projection</td>
</tr>
<tr>
<td class="label">Pedunculopontine Nucleus</td>
<td>Gait and arousal control</td>
</tr>
<tr>
<td class="label">Laterodorsal Tegmental Nucleus</td>
<td>Attention and REM sleep</td>
</tr>
<tr>
<td class="label">Brainstem Motor Nuclei</td>
<td>Cranial nerve motor control</td>
</tr>
<tr>
<td class="label">Spinal Cord (Onuf's nucleus)</td>
<td>Pelvic floor control</td>
</tr>
<tr>
<td class="label">Enteric Nervous System</td>
<td>Gastrointestinal m

...

CHAT Gene

Introduction

Chat Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Pathway Diagram

Mermaid diagram (expand to render)

Knowledge graph relationships for CHAT (311 total edges in KG)

Overview

CHAT (Choline Acetyltransferase) encodes the enzyme responsible for synthesizing the neurotransmitter acetylcholine from choline and acetyl-CoA. CHAT is essential for cholinergic neuron function and is widely used as a specific marker for cholinergic [neurons](/entities/neurons). The enzyme is primarily localized in the cytoplasm of presynaptic nerve terminals, but also associates with synaptic vesicles for regulated neurotransmitter release. [@oda2001]

The CHAT gene is located on chromosome 10q11.23 and spans approximately 46 kb. It contains 14 exons and produces multiple splice variants with distinct tissue distribution patterns. The most studied variants include the 70 kDa cytosolic form (Type I) found in peripheral tissues and the 82 kDa form (Type II) predominant in the brain. [@berse2005]

Protein Structure

The CHAT protein consists of several functional domains:

N-terminal Domain: Contains the acetyl-CoA binding site and facilitates homodimerization
Central Catalytic Core: Houses the active site for acetyl group transfer
C-terminal Region: Involved in substrate (choline) binding and localization to synaptic vesicles

The enzyme requires both choline and acetyl-CoA as substrates, catalyzing the reaction:

Choline + Acetyl-CoA → [Acetylcholine](/entities/acetylcholine) + CoA

This reaction occurs in the cytoplasm of cholinergic neurons, and the resulting acetylcholine is then packaged into synaptic vesicles by the vesicular acetylcholine transporter (VAChT).

Biological Function

Acetylcholine Synthesis

CHAT is the key enzyme in acetylcholine biosynthesis. The reaction mechanism involves:

Substrate Binding: Choline and acetyl-CoA bind to the active site

Catalytic Transfer: The acetyl group is transferred from acetyl-CoA to choline

Product Release: Acetylcholine and CoA are released

The enzyme has a Km of approximately 1-5 mM for choline and 5-15 μM for acetyl-CoA, making choline availability the rate-limiting factor in acetylcholine synthesis.

Cholinergic Neuron Marker

CHAT expression is restricted to cholinergic neurons, making it an ideal marker for:

Basal forebrain cholinergic neurons (projecting to [cortex](/brain-regions/cortex) and hippocampus)
Brainstem motor nuclei (III, IV, VI, X, XII)
Spinal cord motor neurons
Autonomic nervous system preganglionic neurons
Enteric nervous system neurons

Regulation of CHAT Expression

CHAT expression is regulated at multiple levels:

Transcriptional Regulation: NGFI-A (EGR1) and other transcription factors activate CHAT transcription
Alternative Splicing: Multiple splice variants produce tissue-specific isoforms
Epigenetic Regulation: [DNA methylation](/entities/dna-methylation) and histone acetylation influence CHAT expression
Activity-Dependent Modulation: Neuronal activity can upregulate CHAT expression

Disease Associations

Alzheimer's Disease (AD)

CHAT activity is severely reduced in Alzheimer's disease due to the degeneration of basal forebrain cholinergic neurons. This loss is a hallmark of AD neuropathology and underlies the cognitive deficits observed in patients.

Basal Forebrain Degeneration: The [nucleus basalis of Meynert](/entities/nucleus-basalis-meynert) (NBM) shows 50-90% loss of CHAT-positive neurons in AD
Cortical Cholinergic Deficit: Reduced acetylcholine synthesis correlates with cognitive impairment
Therapeutic Implications: AChE inhibitors ([donepezil](/entities/donepezil), [rivastigmine](/entities/rivastigmine), galantamine) aim to compensate for reduced cholinergic signaling

Parkinson's Disease (PD)

CHAT deficiency has also been reported in Parkinson's disease, particularly in:

Pedunculopontine nucleus (PPN) degeneration
Cortical cholinergic deficits contributing to cognitive decline
Interaction with [alpha-synuclein](/mechanisms/alpha-synuclein) pathology

Congenital Myasthenic Syndrome (CMS)

Recessive mutations in CHAT cause CMS type 6 (CHAT-CMS), characterized by:

Episodic apnea (breathing difficulties)
Generalized weakness
Poor response to acetylcholinesterase inhibitors
Reduced CHAT activity at neuromuscular junctions

Other Neurological Disorders

Down Syndrome: Elevated CHAT expression in early stages
Schizophrenia: Altered cholinergic signaling
Amyotrophic Lateral Sclerosis (ALS): Motor neuron CHAT expression changes

Therapeutic Relevance

Biomarker Potential

CHAT activity serves as a biomarker for:

Cholinergic neuron integrity
Disease progression in AD
Efficacy of cholinergic therapies

Gene Therapy Approaches

Experimental approaches include:

Viral vector-mediated CHAT gene delivery
CHAT promoter-driven neurotrophic factor expression
Stem cell-based cholinergic neuron replacement

Pharmacological Modulation

Choline Supplementation: Increases substrate availability
Acetyl-CoA Precursors: Improve acetylcholine synthesis
AChE Inhibitors: Preserve available acetylcholine

Expression Patterns

Brain Regions

CHAT is expressed in discrete neuronal populations:

Peripheral Tissues

Autonomic ganglia
Adrenal medulla
Sweat glands
Urinary bladder

Interacting Proteins

CHAT interacts with several proteins involved in cholinergic signaling:

VAChT (SLC18A3): Vesicular acetylcholine transporter
AChE (ACHE): Acetylcholinesterase for synaptic clearance
Choline Transporter (SLC5A7): High-affinity choline uptake
VAMP2: Synaptic vesicle fusion
Synaptophysin: Synaptic vesicle protein

Animal Models

Knockout Mice

CHAT knockout mice are embryonic lethal, demonstrating the essential role of acetylcholine in development. Conditional knockouts show:

Severe neurological deficits
Reduced viability
Cholinergic system degeneration

Transgenic Models

Human CHAT transgenic mice
Reporter mice (CHAT-GFP, CHAT-LacZ)
Disease model crosses ([APP](/entities/app-protein)/CHAT, α-syn/CHAT)

Research Methods

Detection Techniques

Immunohistochemistry: Antibody-based CHAT detection
In Situ Hybridization: mRNA localization
Enzyme Activity Assays: Radiometric and colorimetric assays
Western Blot: Protein level quantification
RT-PCR: mRNA expression analysis

Background

The study of Chat Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

[Wu D, et al, Choline acetyltransferase: structure, function, and therapeutic potential (2022)](https://pubmed.ncbi.nlm.nih.gov/35687211/)

[Oda Y, Choline acetyltransferase: the role of the N-terminal domain (2001)](https://pubmed.ncbi.nlm.nih.gov/11448503/)

[Berse B, et al, Differential regulation of choline acetyltransferase gene expression by nicotinic signaling in neurons (2005)](https://pubmed.ncbi.nlm.nih.gov/15994099/)

[Mdas MN, et al, Choline acetyltransferase and its antibody (1986)](https://pubmed.ncbi.nlm.nih.gov/2946975/)

[Kuhl D, et al, Cholinergic neurons: molecular diversity and disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32380523/)

[Coppola M, et al, Choline acetyltransferase activity in Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34018097/)

[Schütz B, et al, The cholinergic system in development and disease (2021)](https://pubmed.ncbi.nlm.nih.gov/32998612/)

[Mesulam MM, Cholinergic neurons of the primate basal forebrain: functional diversity and cortical projections (2020)](https://pubmed.ncbi.nlm.nih.gov/30844345/)

[Shen J, et al, Choline acetyltransferase mutations cause congenital myasthenic syndrome (2020)](https://pubmed.ncbi.nlm.nih.gov/31996459/)

[Berlucchi G, The history of the synapse: from Sherrington to the present (2021)](https://pubmed.ncbi.nlm.nih.gov/34358932/)

Pathway Diagram

The following diagram shows the key molecular relationships involving CHAT Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

CHAT Gene

CHAT Gene

Introduction

CHAT Gene

Introduction

Pathway Diagram

Overview

Protein Structure

Biological Function

Acetylcholine Synthesis

Cholinergic Neuron Marker

Regulation of CHAT Expression

Disease Associations

Alzheimer's Disease (AD)

Parkinson's Disease (PD)

Congenital Myasthenic Syndrome (CMS)

Other Neurological Disorders

Therapeutic Relevance

Biomarker Potential

Gene Therapy Approaches

Pharmacological Modulation

Expression Patterns

Brain Regions

Peripheral Tissues

Interacting Proteins

Animal Models

Knockout Mice

Transgenic Models

Research Methods

Detection Techniques

See Also

Background

External Links

References

Pathway Diagram